JSC "Gryndex" (manufacturer responsible for batch release, including batch control/testing)

The drug is used to treat diseases of the peripheral nervous system (e.g., myasthenia, neuropathies), as well as diseases of the central nervous system, such as bulbar paralysis and paresis, or during the recovery period after CNS damage.

Dosage form: solution for injection

ATC: N07AA